There’s a lot to be optimistic about in the Materials sector as 3 analysts just weighed in on Alto Ingredients (ALTO – Research Report), Victoria Gold (VITFF – Research Report) and Curaleaf Holdings (CURLF – Research Report) with bullish sentiments.
Alto Ingredients (ALTO)
H.C. Wainwright analyst Amit Dayal maintained a Buy rating on Alto Ingredients today and set a price target of $10.00. The company’s shares closed last Monday at $4.15, close to its 52-week low of $3.51.
According to TipRanks.com, Dayal is a top 100 analyst with an average return of
Alto Ingredients has an analyst consensus of Moderate Buy, with a price target consensus of $10.00.
Victoria Gold (VITFF)
H.C. Wainwright analyst Heiko Ihle reiterated a Buy rating on Victoria Gold today and set a price target of C$22.00. The company’s shares closed last Monday at $5.47, close to its 52-week low of $4.77.
According to TipRanks.com, Ihle has 0 stars on 0-5 stars ranking scale with an average return of
Victoria Gold has an analyst consensus of Moderate Buy, with a price target consensus of $12.84.
Curaleaf Holdings (CURLF)
Needham analyst Matt McGinley maintained a Buy rating on Curaleaf Holdings today and set a price target of $7.00. The company’s shares closed last Monday at $5.35, close to its 52-week low of $4.48.
According to TipRanks.com, McGinley is a 4-star analyst with an average return of
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Curaleaf Holdings with a $8.57 average price target, implying a 64.2% upside from current levels. In a report issued on October 28, BTIG also initiated coverage with a Buy rating on the stock with a C$10.00 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on ALTO:
- Analysts’ Top Technology Picks: Diodes (DIOD), Kopin (KOPN)
- EVERI REPORTS THIRD QUARTER 2022 RESULTS
- Roivant Sciences Announces Pricing of Primary and Secondary Public Equity Offering
- H.C. Wainwright Sticks to Their Buy Rating for Longboard Pharmaceuticals (LBPH)
- Needham Sticks to Its Buy Rating for Apellis Pharmaceuticals (APLS)